LINC 2022 Programme


LINC 2022, the Leipzig Interventional Course, features state-of-the-art lectures and
more than 40 live cases will be performed from leading interventional centers.

LINC 2022 programme

Find all topics and speakers listed below.

Conference day 1

  • - , Main Arena 1

    New solutions for complex aortoiliac obstructions

    Moderator:
    Dierk Scheinert
    Panel:
    Patrice Mwipatayi, Maria Antonella Ruffino, Peter Goverde, Eric Secemsky
    1. -

      Live case transmission from Leipzig – part I

        Universitätsklinikum, Abt. Angiologie - Live case center - Leipzig
    2. -

      Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: Single-centre data and a review of the literature

        Mohammad Hamady
    3. -

      Initial interim results from the post-market registry of the GORE® VIABAHN® VBX balloon expandable endoprosthesis implanted in peripheral vessels

        Mauro Gargiulo
    4. -

      Following up patients with iliac occlusive disease treated with the GORE® VIABAHN® VBX balloon expandable endoprosthesis – FLEX clinical study

        Jean Bismuth
    5. -

      Outcomes of self-expanding e-PTFE covered stent when treating chronic iliac artery occlusions – a multi-centre experience

        Michele Piazza
    6. -

      Live case transmission from Leipzig – part II

        Universitätsklinikum, Abt. Angiologie - Live case center - Leipzig
    7. -

      Versatility of covered stents in complex aorto-iliac POD lesions and FEVAR/BEVAR

        Markus Steinbauer
    8. -

      FIRST TIME DATA RELEASE: BELSTREAM – 12-month results of study

        Koen Deloose
    9. -

      5-year follow-up of CERAB reconstructions: Single center experience from the Netherlands

        Wilbert M. Fritschy
    10. -

      Multicentre experience on CERAB technique for the treatment option of AIOD – Polish experiences

        Zbigniew Krasinski
    11. -

      Improving outcomes of vascular interventions with AI

        Kak Khee Yeung
    12. -

      Advances in intravascular imaging: Real world evidence and expert consensus

        Eric Secemsky
  • - , Main Arena 2

    Carotid revascularisation – what is new in 2022?

    Moderator:
    Marc van Sambeek, Horst Sievert
    Panel:
    Alison Halliday, Piero Montorsi, Frans Moll, Murat Muzaffer Guclu
    1. -

      Quality assessment of carotid reconstruction – anything new from the German registry?

        Martin Storck
    2. -

      ACST II-trial: Update on latest data and clinical implications

        Alison Halliday
    3. -

      Proximal vs. distal protection for carotid artery stenting: A review of the data

        Piero Montorsi
    4. -

      Proximal protection for carotid artery stenting: A preferred solution for all-comers

        Piero Montorsi
    5. -

      Improving your safety profile through proximal protection: Experiences from a high volume carotid artery stenting center

        Horst Sievert
    6. -

      Live case transmission from Milan

        Centro Cardiologico Monzino - Live case center Milan
    7. -

      TCAR: Patient selection, technique, and role in contemporary practice

        Peter Schneider
    8. -

      CAS in patients with bovine and Type III arch – a single center experience

        Arne Schwindt
  • - , Main Arena 2

    Carotid stenosis treatment: Is the puzzle complete?

    Moderator:
    Sasko Kedev
    Panel:
    Richard Bulbulia, Zsolt Vajda, Koen Deloose
    1. -

      Introduction

        Sasko Kedev
    2. -

      Asymptomatic carotid stenosis treatment: Lessons from > 6000 randomized patients in AST 1 and 2

        Richard Bulbulia
    3. -

      Live case transmission from Münster

        St. Franziskus Hospital - Live case center Münster
    4. -

      ROADSAVER study outcomes: Real-world evidence from a large carotid stenting cohort treated with a dual-layer micromesh stent

        Zsolt Vajda
    5. -

      Live in a box from Milan

        Piero Montorsi
    6. -

      Pieces of puzzle coming together, building a new carotid treatment algorithm

        Koen Deloose
    7. -

      Q&A, discussion, and conclusion

  • - , Main Arena 1

    Opening Symposium: Focus on the lower limb: Novel treatment options from SFA to BTK

    Moderator:
    Dierk Scheinert
    Panel:
    Luis Palena, Michael Lichtenberg, Houman Jalaie, Lieven Maene
    1. -

      Welcome from the moderator

        Dierk Scheinert
    2. -

      Late breaker: 2 year follow-up of SUPERSUB II

        Luis Palena
    3. -

      Discussion

    4. THROMBECTOMY: THE BENEFITS OF MECHANICAL THROMBECTOMY FOR LOWER LIMB TREATMENT

    5. -

      Treating acute limb ischemia with mechanical thrombectomy – case presentation

        Michael Lichtenberg
    6. -

      Mechanical thrombectomy for venous thromboembolism: A pathway to consider?

        Houman Jalaie
    7. -

      Treating venous thromboembolism with mechanical thrombectomy – case presentation

        Michael Lichtenberg
    8. -

      Discussion

    9. -

      Tomorrow’s BTK treatment options – drug eluting resorbable scaffolds

        Lieven Maene
    10. -

      Discussion

    11. -

      Take-home messages

        Dierk Scheinert
  • - , Main Arena 1

    Novel approaches and insights for treatment of complex femoropopliteal disease – part I

    Moderator:
    Thomas Zeller, Peter Schneider
    Panel:
    Gary Ansel, Koen Deloose, Robert Beasley, Erwin Blessing, Rokas Girčius
    1. -

      Serration angioplasty technique for better lumen gain

        Christian Wissgott
    2. -

      RECORDED CASE PRESENTATION: Serranator Serration balloon as primary therapy for CLTI disease

        Michael Lichtenberg
    3. -

      FIRST TIME DATA RELEASE: UltraScore – final results of a multi-center study

        Robert Beasley
    4. -

      FIRST TIME DATA RELEASE: Long-term evidence of directonal atherectomy and DCB: 3-year clinical experience from Australia

        Vikram Puttaswamy
    5. -

      Clinical outcomes with drug-coated balloon alone vs. drug-coated balloon plus provisional stenting: An analysis from the IN.PACT global study 5-year data

        Gary Ansel
    6. -

      BIOPACT RCT: A head-to-head multicenter noninferiority trial of the safety and efficacy of Passeo-18 Lux vs. In.Pact Admiral DCBs in fempop lesions

        Koen Deloose
    7. -

      Live case transmission from Bad Krozingen

        Heart Center - Live case center Bad Krozingen
    8. -

      FIRST TIME DATA RELEASE: Cost-effectiveness of urea excipient-based drug-coated balloons for chronic limb-threatening ischemia from femoropopliteal disease

        Michel Reijnen
    9. -

      5-year results from the Lutonix trial

        Nicolas Shammas
    10. -

      IN.PACT global study 5-year diabetic and gender subgroup outcomes

        Marianne Brodmann
    11. -

      Recent data outcomes in complex femoropopliteal occlusive disease with the GORE® VIABAHN® Endoprosthesis

        Osamu Iida
  • - , Main Arena 2

    Innovative options for patients with end-stage renal disease: Percutaneous creation of AV-access

    Moderator:
    Dimitrios Karnabatidis, Ounali Jaffer
    Panel:
    Jeffrey Hull, Robert Shahverdyan, Jackie Ho, Peter Metzger
    1. -

      Multi-center experience with WavelinQ™ 4F in 120 patients

        Todd Berland
    2. -

      Patient perspective of EndoAVF – insights from a multi-center analysis

        Aurangzaib Khawaja
    3. -

      Single-center experience with WavelinQ™ 4F

        Dimitrios Karnabatidis
    4. -

      Implications of anatomic variations for EndoAVF

        Ounali Jaffer
    5. -

      AVF creation using Ellipsys: Long-term evidence to date

        Jeffrey Hull
    6. -

      AVF creation: Comparing surgical and percutaneous outcomes

        Alexandros Mallios
    7. -

      FIRST TIME DATA RELEASE: Arteriovenous access creation: Updates from the Hamburg experience

        Robert Shahverdyan
  • - , Main Arena 2

    Are we stenting too little, too late? An introduction to the WRAPSODY™ cell-impermeable endoprosthesis and 12-month data

    Moderator:
    Fabrizio Fanelli
    Panel:
    Dheeraj Rajan, Katarzyna Kolasa, Tobias Steinke, Ounali Jaffer
    1. -

      Introduction by the moderator

        Fabrizio Fanelli
    2. -

      The evolution of covered stents

        Tobias Steinke
    3. -

      Live case transmission from Varese

        University of Insubria - Live case center Varese
    4. -

      Clinical trials: WRAPSODY™ FIRST, IDE, and registry

        Dheeraj Rajan
    5. -

      Recorded case presentation

        Matteo Tozzi
    6. -

      The algorithm for covered stent treatment

        Ounali Jaffer
    7. -

      Health economics in covered stent management: An overview

        Katarzyna Kolasa
    8. -

      Final Q&A and wrap up

  • - , Speakers Corner

    Latest results from clinical trials and innovations: Carotid/Venous/AV

    Moderator:
    Manuela Konert, Daniela Branzan
    1. -

      30-day safety outcomes of patients treated with the Roadsaver dual-layer micromesh carotid artery stent via radial or femoral access route: Evidence from a large multicentre European study (ROADSAVER)

        Sasko Kedev
    2. -

      Intravascular lithotripsy (IVL) as new tool in calcified carotid arteries stenosis. Single center experience – LITO–ARCH registry

        Marcin Misztal
    3. -

      30-day safety outcomes of patients <75 and ≥75 years of age treated with the Roadsaver dual-layer micromesh carotid artery stent: Evidence from a large multicentre European study (ROADSAVER)

        Ralf Langhoff
    4. -

      Randomized controlled trial of a first-generation carotid stent vs. the micronet-covered stent: 12-month outcomes

        Savr Bugurov
    5. -

      Mechanical thrombectomy for deep vein thrombosis in real-world patients: 6-month outcomes from the CLOUT registry

        David Dexter
    6. -

      Prospective post-market clinical follow-up study of the endovascular thrombectomy system Aspirex.S in the treatment of acute venous occlusions

        Michael Lichtenberg
    7. -

      Patient selection in NIVL and tips to prevent migration

        Kush Desai
    8. -

      Abdominal Vascular Compression Syndromes (AVCS): Comprehensive evaluation of Median Arcuate Ligament, Nutcracker, May-Thurner, Superior Mesenteric Artery, and Pelvic Venous Congestion Syndromes and intervention algorithm based on interconnectivity of these syndromes

        Kurtis Kim
    9. -

      Conversion of arterio-venous access of hemodialysis to arterio-arterial access for treatment of venous hypertension with central venous occlusion

        Tamer Khafagy
    10. -

      Microwave ablation of varicose veins – early Egyptian experience

        Sohiel Nagib
    11. -

      Will great saphenous vein crossectomy laser ablation be safer and more effective compared to the standard 2 cm distance from the valve laser ablation in management of primary varicose veins in Egypt?

        Sohiel Nagib
    12. -

      SIroliMus coated angioPlasty vs. plain balloon angioplasty in the tREatment of dialySis acceSs dysfunctION (IMPRESSION)

        Chee Wooi Tan
    13. -

      Long term results of Supera in the AVF junta-anastomosis

        Shannon Thomas
    14. -

      Arteriovenous fistula formation with adjuvant endovascular maturation

        Shannon Thomas
    15. -

      Discussion and conclusion

  • - , Main Arena 1

    Status of the SFA treatment paradigm

    Moderator:
    Koen Deloose
    Panel:
    Aloke Finn, Thomas Zeller, Osamu Iida, Marc Bosiers, E. Sebastian Debus
    1. POLYMER-COATED DES: LEARN ABOUT THE EVIDENCE

    2. -

      Pre-clinical experience

        Aloke Finn
    3. -

      Clinical experience

        Thomas Zeller
    4. -

      Clinical experience

        Osamu Iida
    5. -

      Q&A, discussion

    6. ADDITIONAL BENEFITS OF ENDOVASCULAR TREATMENT OVER BYPASS – READY TO MOVE ON?

    7. -

      Zilverpass – 36-month update and health economic snapshot

        Marc Bosiers
    8. -

      Should the endovascular approach be the new frontier?

        E. Sebastian Debus
    9. -

      Q&A, discussion, and conclusion

  • - , Main Arena 2

    Advances in endovascular therapy of deep venous obstructions – part I: Advanced imaging modalities and first European experience with Opticross IVUS in complex venous disease

    Moderator:
    Stephen Black
    Panel:
    Rutger Brans, Gerard O'Sullivan, Mahmood Razavi, Rick de Graaf, Tobias Hirsch
    1. -

      Pelvic vein anatomy and the use of ultrasound to classify the disease according to the 2021 SVP classification

        Tobias Hirsch
    2. -

      The significance of accurate MR-venography before the treatment of iliofemoral thrombosis

        Rick de Graaf
    3. -

      Live case transmission from Modena

        Hesperia Hospital - Live case center Modena
  • - , Main Arena 1

    Novel approaches and insights for treatment of complex femoropopliteal disease – part II

    Moderator:
    Koen Deloose, Yann Gouëffic
    Panel:
    Marianne Brodmann, Antonio Micari, John Laird, Gireesh Mukund Warawdekar
    1. -

      Optimizing PTA following atherectomy in complex lower limb lesions: 12-month results of the DISSECT study

        Michael Lichtenberg
    2. -

      FIRST TIME DATA RELEASE: Treating common femoral artery steno-occlusive lesions with an endovascular approach using DA+DCB: 3-year follow-up in 75 patients

        Angelo Cioppa
    3. -

      Live case transmission from Leipzig

        Universitätsklinikum, Abt. Angiologie - Live case center - Leipzig
    4. -

      Safety, effectiveness, and mid-term follow-up in 400 consecutive patients with moderate to severely calcified lesions undergoing phoenix atherectomy

        Sorin Giusca
    5. -

      Directional atherectomy (DA) followed by DCB to treat long, calcified femoropopliteal artery lesions: The REALITY study

        Thomas Zeller
    6. -

      EMINENT RCT (Eluvia vs. BMS): 12-month primary endpoint data and subset analysis

        Yann Gouëffic
    7. -

      MIMICS-3D 3-year results: Compelling clinical outcomes with BioMimics 3D in complex patients and lesions

        Michael Lichtenberg
    8. -

      TINTIN trial 3-year follow-up

        Koen Deloose
    9. -

      Live case transmission from Münster

        St. Franziskus Hospital - Live case center Münster
    10. -

      FIRST TIME DATA RELEASE: Predictors of drug-coated balloon efficacy in femoropopliteal intervention: Insights from a patient-level pooled analysis

        Prakash Krishnan
    11. -

      5-year results from the IN.PACT global study pre-specified cohorts: In-stent restenosis, chronic total occlusions, and long lesions

        Antonio Micari
    12. -

      Safety and efficacy of Passeo-18 Lux in long lesions: Pooled results from the BIOLUX P-III and BIOLUX P-III Spain studies

        Marianne Brodmann
    13. -

      Stellarex complex lesion subset analysis from the SAVER real world registry

        Konstantinos Stavroulakis
  • - , Main Arena 2

    Advances in endovascular therapy of deep venous obstructions – part II: Latest scientific data and new horizons

    Moderator:
    Rick de Graaf
    Panel:
    Rutger Brans, Gerard O'Sullivan, Kenneth Rosenfield
    1. -

      FIRST TIME DATA RELEASE: ABRE 24-month subgroup outcomes

        Erin Murphy
    2. -

      VIVO 3-year data

        Paul Gagne
    3. -

      VERNACULAR (Venovo) 3-year data

        Michael Dake
    4. -

      Venovo venous registry: 36-month data report from a real world registry

        Michael Lichtenberg
    5. -

      Preliminary data of multi-center RCT comparing venous stenting with conservative treatment in patients with deep venous obstructions

        Houman Jalaie
    6. -

      Anti-inflammation treatment for DVT

        David Dexter
    7. -

      Recorded case presentation

        Gerard O'Sullivan
    8. -

      Cost of venous leg ulcers related to deep venous disease and its implications

        Raghu Kolluri
    9. -

      Deep venous obstruction and superficial reflux

        Ronald Winokur
    10. -

      Endovascular solutions in complex massive pulmonary embolism: When and how

        Bruno Freitas
    11. -

      Best practice for treatment of PE in 2022 – the role of endovascular therapy

        Kenneth Rosenfield
Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

more info
  • Strictly necessary

    We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • Analytical (Tracking) Cookies

    We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Functionality Cookies

    Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.